|
시장보고서
상품코드
1890980
급성 췌장염 시장 : 병인별, 치료 유형별, 투여 경로별, 환자 그룹별, 최종사용자별, 유통 채널별, 지역별Acute Pancreatitis Market, By Etiology, By Treatment Type, By Route of Administration, By Patient Group, By End User, By Distribution Channel, By Geography |
||||||
급성 췌장염 시장은 2025년에 36억 2,000만 달러로 추정되며, 2032년까지 54억 1,000만 달러에 달할 것으로 예측됩니다. 2025-2032년까지 CAGR 5.9%로 성장할 것으로 전망됩니다.
| 보고서 내용 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2024년 | 2025년 시장 규모: | 36억 2,000만 달러 |
| 과거 데이터 대상 기간: | 2020-2024년 | 예측 기간: | 2025-2032년 |
| 예측 기간 2025-2032년: | 5.90% | 2032년 예측치: | 54억 1,000만 달러 |
급성 췌장염은 심한 복통, 췌장 효소 수치 상승, 생명을 위협할 수 있는 합병증을 특징으로 하는 췌장의 심각한 염증성 질환으로 즉각적인 의료적 개입이 필요한 질환입니다. 세계 급성 췌장염 시장은 이 복잡한 의료 응급 상황에 대처하기 위해 고안된 진단 도구, 치료적 개입, 지지요법 솔루션의 종합적인 범위를 포괄합니다.
이 시장에는 CT 스캔, MRI 시스템 등 첨단 영상 기술, 효소 검출용 검사 장비, 통증 관리제 및 효소 보충제를 포함한 의약품 치료, 내시경적 개입을 위한 전문 의료기기 등이 포함됩니다. 담석증 유병률 증가, 알코올 섭취, 생활습관 관련 위험요인이 전 세계 급성 췌장염 발생률 증가에 크게 기여하고 있습니다. 전 세계 의료 시스템에서 이 질환과 관련된 응급실 방문 및 입원이 급증하고 있으며, 효과적인 치료법에 대한 수요가 크게 증가하고 있습니다.
시장 역학
세계 급성 췌장염 시장은 주로 몇 가지 강력한 요인에 의해 주도되고 있으며, 이러한 요인들이 복합적으로 작용하여 견고한 성장 궤도를 유지하고 있습니다. 급성 췌장염 환자의 약 40-50%를 차지하는 담석증의 증가는 특히 식습관과 좌식생활이 담낭 합병증의 원인이 되는 선진국에서 주요 시장 촉진요인으로 작용하고 있습니다. 전 세계적으로, 특히 신흥 경제국에서 알코올 소비가 증가함에 따라 알코올성 췌장염 환자가 크게 증가하고 있으며, 이는 치료 솔루션에 대한 지속적인 수요를 창출하고 있습니다. 고해상도 CT 스캐너, 자기공명 담관 췌관 조영술(MRCP), 내시경 초음파 시스템 등 진단 영상 기술의 발전은 조기 발견 및 중증도 평가 능력에 혁명을 가져왔습니다.
그러나 첨단 진단 장비와 전문 치료의 높은 비용 등 눈에 띄는 제약이 존재하며, 자원이 부족한 의료 환경에서는 접근성이 제한되어 있습니다. 급성 췌장염의 관리는 복잡하고 소화기내과, 외과, 중환자실 전문의가 참여하는 다학제간 협진 접근이 필요하기 때문에 표준화된 치료 프로토콜을 확립하는 것이 과제입니다. 또한, 췌장염 치료에 특화된 약물이 부족하고, 현재 치료는 주로 지지요법에 중점을 두고 있는 것도 시장의 큰 억제요인으로 작용하고 있습니다. 그러나 고령자가 췌장 질환에 대한 감수성이 높기 때문에 전 세계 고령화 인구의 증가와 함께 큰 기회를 창출하고 있습니다. 개발도상국의 의료비 지출 증가와 의료보험 적용 범위 확대가 맞물리면서 시장에 유리한 조건이 조성되고 있습니다. 진단 영상에 인공지능을 통합하고 맞춤형 의료 접근법을 개발하는 것은 급성 췌장염 치료의 시장 확대와 혁신을 위한 유망한 기회를 제공하고 있습니다.
본 조사의 주요 특징
- 세계의 급성 췌장염 시장에 대한 상세한 분석과 2024년을 기준 연도, 예측 기간(2025-2032년) 동안의 시장 규모(10억 달러)와 연평균 성장률(CAGR)을 조사하여 전해드립니다.
- 또한, 다양한 부문의 잠재적 수익기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 설명합니다.
- 시장 촉진요인, 억제요인, 기회, 신제품 출시 또는 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요한 정보도 제공합니다.
- 이 보고서는 다음과 같은 매개 변수를 기반으로 세계 급성 췌장염 시장의 주요 기업 프로파일을 제공합니다. 회사 개요,제품 포트폴리오,주요 하이라이트,재무 실적,전략
- 이 보고서는 마케팅 담당자와 기업 경영진이 향후 제품 출시, 유형 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있도록 돕습니다.
- 이 세계 급성 췌장염 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 금융 분석가 등 이 산업의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 급성 췌장염 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것으로 보입니다.
목차
제1장 조사 목적과 가정
- 조사 목적
- 가정
- 약어
제2장 시장 범위
- 보고서 개요
- 시장 정의와 범위
- 주요 요약
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 성장 촉진요인
- 성장 억제요인
- 기회
- 영향 분석
- 규제 환경
- 제품 발매·승인
- PEST 분석
- Porters 분석
- 인수합병 동향
- 산업 동향
제4장 세계의 급성 췌장염 시장 : 병인별, 2020-2032년
- 담석에 의한
- 알코올 유발성
- 고중성지방혈증
- 약제 유발성
- ERCP 후
- 자가면역성
- 유전성
- 특발성
제5장 세계의 급성 췌장염 시장 : 치료 유형별, 2020-2032년
- 약제 기반 치료
- 의료기기 기반 치료
- 영양 서포트
- 기타(항산화 치료)
제6장 세계의 급성 췌장염 시장 : 투여 경로별, 2020-2032년
- 경구
- 비경구
- 기타
제7장 세계의 급성 췌장염 시장 : 환자 그룹별, 2020-2032년
- 성인
- 소아
제8장 세계의 급성 췌장염 시장 : 최종사용자별, 2020-2032년
- 병원
- 전문 클리닉
- 외래 수술 센터
- 이미징 센터
- 연구기관 및 학술기관
제9장 세계의 급성 췌장염 시장 : 유통 채널별, 2020-2032년
- 병원 약국
- 소매 약국
- 온라인 약국
제10장 세계의 급성 췌장염 시장 : 지역별, 2020-2032년
- 북미
- 미국
- 캐나다
- 라틴아메리카
- 브라질
- 아르헨티나
- 멕시코
- 기타 라틴아메리카 국가
- 유럽
- 독일
- 영국
- 스페인
- 프랑스
- 이탈리아
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- 호주
- 한국
- ASEAN
- 기타 아시아태평양
- 중동
- GCC
- 이스라엘
- 기타 중동 국가
- 아프리카
- 남아프리카공화국
- 북아프리카
- 중앙아프리카
제11장 경쟁 구도
- Boston Scientific
- AbbVie
- Cook Medical
- Medtronic
- Olympus Corporation
- Fujifilm Healthcare
- Pentax Medical
- ConMed
- Teleflex
- Baxter International
- Braun Melsungen AG
- Fresenius Kabi
- Abbott Laboratories
- ICU Medical
- ERBE Elektromedizin
제12장 애널리스트의 추천사항
- 기회
- Coherent Opportunity Map
제13장 참고문헌과 조사 방법
- 참고문헌
- 조사 방법
- 출판사 소개
Acute Pancreatitis Market is estimated to be valued at USD 3.62 Bn in 2025 and is expected to reach USD 5.41 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.9% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 3.62 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 5.90% | 2032 Value Projection: | USD 5.41 Bn |
Acute pancreatitis represents a critical inflammatory condition of the pancreas that demands immediate medical intervention, characterized by severe abdominal pain, elevated pancreatic enzymes, and potential life-threatening complications. The global acute pancreatitis market encompasses a comprehensive range of diagnostic tools, therapeutic interventions, and supportive care solutions designed to address this complex medical emergency.
This market includes advanced imaging technologies such as CT scans and MRI systems, laboratory diagnostic equipment for enzyme detection, pharmaceutical treatments including pain management medications and enzyme supplements, as well as specialized medical devices for endoscopic interventions. The rising prevalence of gallstone disease, alcohol consumption, and lifestyle-related risk factors has significantly contributed to the increasing incidence of acute pancreatitis worldwide. Healthcare systems globally are witnessing a surge in emergency department visits and hospitalizations related to this condition, driving substantial demand for effective treatment modalities.
Market Dynamics
The global acute pancreatitis market is primarily driven by several compelling factors that collectively fuel its robust growth trajectory. The increasing prevalence of gallstone disease, which accounts for approximately 40-50% of acute pancreatitis cases, serves as a major market driver, particularly in developed countries where dietary habits and sedentary lifestyles contribute to gallbladder complications. Rising alcohol consumption patterns globally, especially in emerging economies, significantly contribute to alcohol-induced pancreatitis cases, creating sustained demand for treatment solutions. Technological advancements in diagnostic imaging, including high-resolution CT scanners, magnetic resonance cholangiopancreatography (MRCP), and endoscopic ultrasound systems, are revolutionizing early detection and severity assessment capabilities.
However, the market faces notable restraints including the high cost of advanced diagnostic equipment and specialized treatments, which limit accessibility in resource-constrained healthcare settings. The complexity of acute pancreatitis management requires multidisciplinary approaches involving gastroenterologists, surgeons, and critical care specialists, creating challenges in standardized treatment protocols. Additionally, the lack of specific therapeutic drugs for pancreatitis treatment, with current management primarily focusing on supportive care, represents a significant market limitation. Nevertheless, substantial opportunities emerge from the growing aging population worldwide, as elderly individuals demonstrate higher susceptibility to pancreatic disorders. Increasing healthcare expenditure in developing nations, coupled with expanding medical insurance coverage, creates favorable market conditions. The integration of artificial intelligence in diagnostic imaging and the development of personalized medicine approaches present lucrative opportunities for market expansion and innovation in acute pancreatitis care.
Key Features of the Study
- This report provides in-depth analysis of the global acute pancreatitis market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global acute pancreatitis market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Boston Scientific, AbbVie, Cook Medical, Medtronic, Olympus Corporation, Fujifilm Healthcare, Pentax Medical, ConMed, Teleflex, Baxter International, B. Braun Melsungen AG, Fresenius Kabi, Abbott Laboratories, ICU Medical, and ERBE Elektromedizin
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global acute pancreatitis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global acute pancreatitis market
Market Segmentation
- Etiology Insights (Revenue, USD Bn, 2020 - 2032)
- Gallstone-induced
- Alcohol-induced
- Hypertriglyceridemia-induced
- Drug-induced
- Post-ERCP
- Autoimmune
- Genetic
- Idiopathic
- Treatment Type Insights (Revenue, USD Bn, 2020 - 2032)
- Drug Based Therapy
- Analgesics
- Opioids
- Non-opioid analgesics
- Antiemetics
- Proton Pump Inhibitors (PPIs)
- Somatostatin and Analogues
- Intravenous Fluid Therapy Agents (Lactated Ringer's and Normal saline)
- Pancreatic Enzyme Supplements
- Device-Based Therapy
- Intravenous Fluids
- Endoscopic Retrograde Cholangiopancreatography (ERCP)
- Nutritional Support
- Others (Antioxidant Treatment)
- Route of Administration Insights (Revenue, USD Bn, 2020 - 2032)
- Oral
- Parenteral
- Others
- Patient Group Insights (Revenue, USD Bn, 2020 - 2032)
- Adult
- Pediatric
- End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Diagnostic Imaging Centers
- Research and Academic Institutes
- Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
- Hospital pharmacies
- Retail pharmacies
- Online pharmacies
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Boston Scientific
- AbbVie
- Cook Medical
- Medtronic
- Olympus Corporation
- Fujifilm Healthcare
- Pentax Medical
- ConMed
- Teleflex
- Baxter International
- Braun Melsungen AG
- Fresenius Kabi
- Abbott Laboratories
- ICU Medical
- ERBE Elektromedizin
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Acute Pancreatitis Market, By Etiology
- Global Acute Pancreatitis Market, By Treatment Type
- Global Acute Pancreatitis Market, By Route of Administration
- Global Acute Pancreatitis Market, By Patient Group
- Global Acute Pancreatitis Market, By End User
- Global Acute Pancreatitis Market, By Distribution Channel
- Global Acute Pancreatitis Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Acute Pancreatitis Market, By Etiology, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Gallstone-induced
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Alcohol-induced
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Hypertriglyceridemia-induced
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Drug-induced
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Post-ERCP
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Autoimmune
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Genetic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Idiopathic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Acute Pancreatitis Market, By Treatment Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Drug Based Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Analgesics
- Opioids
- Non-opioid analgesics
- Antiemetics
- Proton Pump Inhibitors (PPIs)
- Somatostatin and Analogues
- Intravenous Fluid Therapy Agents (Lactated Ringer's and Normal saline)
- Pancreatic Enzyme Supplements
- Device-Based Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Intravenous Fluids
- Endoscopic Retrograde Cholangiopancreatography (ERCP)
- Nutritional Support
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others (Antioxidant Treatment)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Acute Pancreatitis Market, By Route of Administration, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Acute Pancreatitis Market, By Patient Group, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Acute Pancreatitis Market, By End User, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Diagnostic Imaging Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Research and Academic Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Acute Pancreatitis Market, By Distribution Channel, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospital pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Retail pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Online pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
10. Global Acute Pancreatitis Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Etiology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Etiology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Etiology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Etiology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Etiology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Etiology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
11. Competitive Landscape
- Boston Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AbbVie
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cook Medical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medtronic
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Olympus Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Fujifilm Healthcare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pentax Medical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- ConMed
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Teleflex
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Baxter International
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Braun Melsungen AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Fresenius Kabi
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- ICU Medical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- ERBE Elektromedizin
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
12. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
13. References and Research Methodology
- References
- Research Methodology
- About us
